Gordon joined CHaRT in March 2014 as a Trial Manager. Gordon manages the Treatment of Advanced Glaucoma Study (TAGS) and helps manage the Total or Partial Knee Arthroplasty Trial (TOPKAT). TAGS is a multi-centre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma. TOPKAT is a multi-centre randomised controlled trial designed to examine the clinical- and cost-effectiveness of total and partial knee replacements for medial compartmental osteoarthritis.
Previously, Gordon was based in the Psychiatry research group at the University of Aberdeen where he ran a Chief Scientist Office-funded randomised controlled trial investigating ketamine as the anaesthetic for electro-convulsive therapy (ECT). He was also employed by the Scottish Mental Health Research Network http://www.smhrn.org.uk/ to facilitate ongoing research in that group.
Gordon was awarded a PhD in Psychology by the University of Nottingham in 2007. This used laboratory-based behavioural experiments to investigate the factors involved in learning on a popular decision-making task: the Iowa Gambling Task. He then conducted post-doctoral research on the relationships between impulsivity, attentional bias and alcohol consumption in adolescents (paper), at the Department of Psychology at the University of Liverpool until 2010.
Decision-making, impulsivity, inhibitory control, and the role of emotion in these processes. The development of addiction. The effects on cognition of ECT. Randomised controlled trials. RCTs.
Gordon is employed as the Trial Manager for the Treatment of Advanced Glaucoma Study (TAGS). This is a multicentre randomised controlled trial comparing primary medical treatment with primary surgery (trabeculectomy) for people with newly diagnosed advanced glaucoma.
- Further Info